Abstract
The detection of chemically-reactive, electrophilic metabolites poses a particular problem in the discovery and development of drug candidates in pharmaceutical research, inasmuch as it is not possible to accurately predict the likely toxicological consequences of these intermediates in animal safety studies or in clinical trials. Advances in analytical instrumentation (notably liquid chromatography-tandem mass spectrometry [LC-MS/MS]) have facilitated the detection of reactive intermediates through the identification of the glutathione (GSH) adducts to which they normally give rise, while the increased use of radiolabeled tracers in drug development permits an early assessment to be made of the propensity of a drug candidate to undergo covalent binding to cellular macromolecules. Unfortunately, these advances in analytical methods for the detection and characterization of reactive drug metabolites have far outstripped our understanding of the mechanisms of foreign compound-mediated toxicities at the molecular level, and of the role of both covalent binding and oxidative stress in the cascade of events that lead ultimately to cellular injury or immune-mediated toxicities. In light of these uncertainties, it seems reasonable to argue that one should attempt to minimize, through structural modification, the extent to which a drug candidate undergoes metabolism to reactive intermediates. Therefore, it becomes imperative to have close collaboration between Drug Metabolism scientists and their counterparts in Medicinal Chemistry during both the discovery and early development phases.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Ortiz de Montellano, P. R. (1975). In “Cytochrome P-450. Structure, Mechanism and Biochemistry,” 2nd edition., edited by P. R. Ortiz de Montellano, Plenum Press, New York, pp. 245–303.
Pearson, P. G., Threadgill, M. D., Howald, W. N., and Baillie, T. A. (1988). Applications of tandem mass spectrometry to the characterization of derivatized glutathione conjugates. Studies with S-(N-methylcarbamoyl)glutathione, a metabolite of the antineoplastic agent N-methylformamide. Biomed. Environ. Mass Spectrom., 16, 51–56.
Thomassen, D., Martin, B. M., Martin, J. L., Pumford, N. R., and Pohl, L. R. (1990). Characterization of a halothane induced trifluoroacetylated 100 kDa neoantigen that is related to a glucose-regulated protein. FASEB J, 4, A599.
Kassahun, K., Pearson, P.G., Tang, W., McIntosh, I., Leung, K., Elmore, C., Dean, D., Doss, G. and Baillie, T. A. (2000). Studies on the metabolism of troglitazone to reactive intermediates in vitro and in vivo. Evidence for novel biotransformation pathways involving quininomethide formation and thiazolidinedione ring scission — submitted.
Kohlroser, J., Mathai, J., Reichheld, J., Banner, B. F. and Bonkovsky, H. L. (2000). Hepatotoxicity due to troglitazone: report of two cases and review of adverse events reported to the United States Food and Drug Administration. Am. J. Gastroenterol, 95, 272–276.
Baillie, T. A., and Davis, M.R. (1993). Mass spectrometry in the analysis of glutathione conjugates. Biol. Mass Spectrom., 22, 319–325.
Pumford, N. R., and Halmes, N. C. (2000). Protein targets of xenobiotic reactive intermediates. Annu. Rev. Pharmacol. Toxicol., 37, 91–117.
Nelson, S. D., and Pearson, P. G. (1990). Covalent and noncovalent interactions in acute lethal cell injury caused by chemicals. Annu. Rev. Pharmacol. Toxicol., 30, 169–195.
Uetrecht, J. P. (1999). New concepts in immunology relevant to idiosyncratic drug reactions: the “danger hypothesis” and innate immune system. Chem. Res. Toxicol., 12, 387–395.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer Science+Business Media New York
About this chapter
Cite this chapter
Baillie, T.A., Kassahun, K. (2001). Biological Reactive Intermediates in Drug Discovery and Development. In: Dansette, P.M., et al. Biological Reactive Intermediates VI. Advances in Experimental Medicine and Biology, vol 500. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-0667-6_5
Download citation
DOI: https://doi.org/10.1007/978-1-4615-0667-6_5
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-5185-6
Online ISBN: 978-1-4615-0667-6
eBook Packages: Springer Book Archive